Macrogenics Inc (MGNX)
4.37
-0.75
(-14.65%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.05
(+1.14%)
After-Hours: 20:00
Macrogenics Enterprise Value: 89.16M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 89.16M |
| May 16, 2024 | 136.45M |
| May 15, 2024 | 110.77M |
| May 14, 2024 | 94.48M |
| May 13, 2024 | 90.10M |
| May 10, 2024 | 23.08M |
| May 09, 2024 | 734.60M |
| May 08, 2024 | 733.97M |
| May 07, 2024 | 821.03M |
| May 06, 2024 | 841.07M |
| May 03, 2024 | 797.23M |
| May 02, 2024 | 767.93M |
| May 01, 2024 | 788.58M |
| April 30, 2024 | 740.41M |
| April 29, 2024 | 742.91M |
| April 26, 2024 | 726.64M |
| April 25, 2024 | 714.76M |
| April 24, 2024 | 797.96M |
| April 23, 2024 | 831.12M |
| April 22, 2024 | 779.82M |
| April 19, 2024 | 792.33M |
| April 18, 2024 | 821.11M |
| April 17, 2024 | 822.99M |
| April 16, 2024 | 859.27M |
| April 15, 2024 | 875.54M |
| Date | Value |
|---|---|
| April 12, 2024 | 913.07M |
| April 11, 2024 | 973.76M |
| April 10, 2024 | 957.49M |
| April 09, 2024 | 948.11M |
| April 08, 2024 | 963.75M |
| April 05, 2024 | 956.87M |
| April 04, 2024 | 928.09M |
| April 03, 2024 | 670.96M |
| April 02, 2024 | 648.44M |
| April 01, 2024 | 692.86M |
| March 31, 2024 | 736.65M |
| March 28, 2024 | 691.09M |
| March 27, 2024 | 706.10M |
| March 26, 2024 | 659.81M |
| March 25, 2024 | 671.69M |
| March 22, 2024 | 676.07M |
| March 21, 2024 | 731.02M |
| March 20, 2024 | 731.02M |
| March 19, 2024 | 742.89M |
| March 18, 2024 | 744.13M |
| March 15, 2024 | 764.74M |
| March 14, 2024 | 772.85M |
| March 13, 2024 | 804.07M |
| March 12, 2024 | 869.00M |
| March 11, 2024 | 827.79M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.99M
Minimum
Jun 16 2022
1.796B
Maximum
Apr 29 2021
559.17M
Average
378.73M
Median
Enterprise Value Benchmarks
| Moderna Inc | 42.41B |
| Allurion Technologies Inc | 94.14M |
| Novavax Inc | 1.604B |
| United Therapeutics Corp | 10.06B |
| MEI Pharma Inc | -35.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -52.19M |
| Revenue (Quarterly) | 9.104M |
| Total Expenses (Quarterly) | 62.85M |
| EPS Diluted (Quarterly) | -0.84 |
| Gross Profit Margin (Quarterly) | 76.76% |
| Profit Margin (Quarterly) | -573.3% |
| Earnings Yield | -8.93% |
| Normalized Earnings Yield | -52.81 |